Totonchy Study Guide - work in progress

studied byStudied by 0 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 45

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

46 Terms

1

What does the suffix "-ximab" indicate about a monoclonal antibody?

It is chimeric

New cards
2

What does the suffix "-zumab" indicate about a monoclonal antibody?

It is humanized

New cards
3

What does the suffix "-omab" indicate about a monoclonal antibody?

It is mouse-derived

New cards
4

What does the suffix "-umab" indicate about a monoclonal antibody?

It is fully human

New cards
5

Rituximab is a monoclonal antibody. What type is it based on its name?

Chimeric

New cards
6

Trastuzumab is a monoclonal antibody. What type is it based on its name?

Humanized

New cards
7

Muromonab is a monoclonal antibody. What type is it based on its name?

Mouse-derived

New cards
8

Adalimumab is a monoclonal antibody. What type is it based on its name?

Fully human

New cards
9

Bevacizumab is a monoclonal antibody. What type is it based on its name?

Humanized

New cards
10

Cetuximab is a monoclonal antibody. What type is it based on its name?

Chimeric

New cards
11

Which applications of mAb therapeutics require the Fc region?

TNF alpha therapeutics

  • Infliximab

  • Adalimumab

  • Etanercept

New cards
12

What is one stability advantage of nanobodies compared to mammalian immunoglobulins?

Nanobodies are more resistant to pH changes and denaturation

New cards
13

Nanobodies are easier to manufacture because they are composed of only ______

one protein

New cards
14

True or False: Nanobodies have a longer half-life than mammalian immunoglobulins

False. Nanobodies have a shorter half-life compared to mammalian immunoglobulins

New cards
15

What is one drawback of the small size of nanobodies as therapeutics?

Reduced bioavailability

New cards
16

True or False: Nanobodies do not require an identified target for their use.

False. Nanobodies require an identified target for therapeutic applications

New cards
17

The Fc region of a monoclonal antibody is required for applications such as ______ therapeutics

TNF alpha

New cards
18

What does an antibody with an Fc region look like?

See image

<p>See image</p>
New cards
19

Name three monoclonal antibodies used as TNF alpha therapeutics.

Infliximab, Adalimumab, and Etanercept

New cards
20

Which applications require two antigen binding sites and what are these antibodies

called?

Cross linking

  • Emicizumab

  • Bispecific antibody

New cards
21

Which applications require a small structure like a fragment?

Single Chain mAb application

  • Nanobody

New cards
22

What terms are used for therapeutics that use the patient’s own cells?

Autogenic/autologous

New cards
23

What terms are used for therapeutics that use other people’s cells?

Allogenic/heterologous

New cards
24

What is a major limiting factor for the development of CAR T cell therapeutics?

The need for a defined protein target

New cards
25

Why must CAR T cell targets be highly specific?

To avoid off-target toxicities

New cards
26

True or False: CAR T cell therapy can target any protein regardless of its specificity

False. CAR T cell therapy requires a specific target to minimize off-target toxicities

New cards
27

What is an example of "on-target but off-tumor" toxicity in CAR T cell therapy?

Targeting CD19 in tumor cells but also destroying normal B cells that express CD19, leading to immunosuppression

New cards
28

What systemic toxicity is commonly associated with CAR T cell therapy?

Cytokine storm caused by the activation and proliferation of CAR T cells

New cards
29

The systemic cytokine toxicities in CAR T cell therapy result from the activation of the ______

immune system

New cards
30

What is the goal of gene silencing in gene therapy?

To reduce or prevent the expression of a protein from a mutated gene

New cards
31

True or False: Gene silencing is a permanent solution to fix defective genes

False. Gene silencing is temporary and requires continuous therapy

New cards
32

What is the advantage of gene silencing in gene therapy?

It eliminates overactive defective genes without causing permanent alterations

New cards
33

What is the purpose of genome editing in gene therapy?

To fix the mutated gene directly

New cards
34

True or False: Genome editing in gene therapy has no risks of unintended effects.

False. Genome editing can cause off-target mutations

New cards
35

What is ectopic expression in gene therapy?

Adding a good copy of the mutated gene to restore function

New cards
36

Ectopic expression often uses ______, which can be dangerous

viral vectors

New cards
37

What is a disadvantage of ectopic expression in gene therapy?

It may not result in long-term effects for all applications

New cards
38

What are the three approaches for gene therapy?

  • Gene silencing

  • Genome editing

  • Ectopic expression

New cards
39

Which type of virus used in gene therapy is mostly episomal but can also integrate?

Adeno-associated virus (AAV)

New cards
40

True or False: Adeno-associated virus (AAV) is always an integrating vector.

False. AAV is mostly episomal but can sometimes integrate

New cards
41

What type of vector is lentivirus in gene therapy?

Integrating vector

New cards
42

The ______ platform is an episomal vector used in gene therapy

HSV1 STAR-D

New cards
43

True or False: Lentivirus is an episomal vector.

False. Lentivirus is an integrating vector

New cards
44

What is the only FDA approved oncolytic therapeutic (only specific therapeutic

mentioned on the exam)

Imlygic

New cards
45

What are the ethical and practical reasons behind placebo choice for vaccine clinical trials.

Should mimic the same side effects but still not put the patient at risk. Patients

should still have equal protection from the disease.

New cards
46

Which vaccine types require specific target antigens to be selected during development?

  • Subunit

  • Recombinant

  • mRNA

  • Viral vector

  • Conjugate

New cards

Explore top notes

note Note
studied byStudied by 1 person
86 days ago
5.0(1)
note Note
studied byStudied by 14 people
761 days ago
5.0(2)
note Note
studied byStudied by 66 people
511 days ago
5.0(1)
note Note
studied byStudied by 14 people
953 days ago
5.0(1)
note Note
studied byStudied by 5 people
926 days ago
4.0(1)
note Note
studied byStudied by 10 people
895 days ago
5.0(1)
note Note
studied byStudied by 11 people
972 days ago
4.5(2)
note Note
studied byStudied by 5237 people
150 days ago
4.4(9)

Explore top flashcards

flashcards Flashcard (28)
studied byStudied by 7 people
662 days ago
5.0(1)
flashcards Flashcard (96)
studied byStudied by 73 people
748 days ago
5.0(5)
flashcards Flashcard (43)
studied byStudied by 3 people
635 days ago
5.0(1)
flashcards Flashcard (30)
studied byStudied by 8 people
789 days ago
5.0(1)
flashcards Flashcard (170)
studied byStudied by 7 people
121 days ago
5.0(1)
flashcards Flashcard (32)
studied byStudied by 41 people
97 days ago
5.0(1)
flashcards Flashcard (1000)
studied byStudied by 29 people
852 days ago
4.0(1)
flashcards Flashcard (53)
studied byStudied by 3742 people
709 days ago
4.2(54)
robot